News
Artera Receives CE Marks for AI-Powered Prostate and Breast Cancer Tests
3+ hour, 57+ min ago (184+ words) May 5, 2026 | Breast, Cancer, Digital Pathology | Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced it has received CE marking under the European Union In Vitro Diagnostic Regulation for the Artera AI Prostate Biopsy Assay and the Artera…...
NIH awards $850, 000 to support menstrual blood test for endometriosis
1+ mon, 5+ day ago (396+ words) Mar 31, 2026 | Womens Health | Investigators at Northwell Health's Feinstein Institutes for Medical Research have received a total of $850, 000 in prize funding from the National Institutes of Health's Rapid Acceleration of Diagnostics Technology (RADx Tech) program to accelerate development of a noninvasive…...
Ultrasensitive ct DNA Test Outperforms Standard Metrics in Predicting Breast Cancer Outcomes After Neoadjuvant Therapy
1+ mon, 1+ week ago (261+ words) Mar 25, 2026 | Breast | A new prospective study has found that circulating tumor DNA (ct DNA) testing using Ne XT Personal, developed by Personalis, Inc, outperforms traditional prognostic markers'including pathologic complete response (p CR) status, nodal status, and tumor grade'in predicting outcomes…...